In April 1998, a group of determined scientists, inventors and visionaries founded the company now known as TAE Technologies with $1000 and one goal in mind: Creating a source of safe, carbon-free, on-demand energy that doesn’t harm the environment and is available to everyone equally around the world.
As it pursues energy’s Holy Grail, TAE Technologies seeks to market decades of R&D.
A private venture pursuing fusion power technology has stumbled on a potent way to kill cancer cells while methodically marching toward the Holy Grail of energy production.
Technology developed to try to crack the code of nuclear fusion — that elusive type of nuclear energy that powers the sun — is now being repurposed to kill cancer.
TAE Technologies has spawned a spinoff focusing on a novel type of cancer therapy. TAE Life Sciences will take advantage of the company’s accelerator-based beam technology.